Regarding CIU, it was reported that urticaria patients are characterized by overexpression of MRGPRX2 [20], while a newer publication confirmed this by also showing enhanced skin reactivity of patients to MRGPRX2 drug ligands [93]. This evidence concerns the gene MRGPRX2 and urticaria.